seed
Stage
2
Investors
About
SiSaf is a biopharmaceutical company developing RNA therapeutics using proprietary bioabsorbable silicon-based delivery technology, targeting cancer and musculoskeletal disorders.
Explore SiSaf's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.